Frankfurt, Germany

Andreas Haubrich

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Sanofi-A Ventis Deutschland Gmbh. Active years: 2020.


% Patents Active = 100.0


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Andreas Haubrich: Innovator in Squalene Production

Introduction

Andreas Haubrich is a notable inventor based in Frankfurt, Germany. He has made significant contributions to the field of biochemistry, particularly in the production of valuable compounds from yeast. His innovative approach has led to advancements in the extraction of squalene and sterols, which are important for various applications in pharmaceuticals and cosmetics.

Latest Patents

Andreas Haubrich holds a patent for the "Production of squalene and/or sterol from cell suspensions of fermented yeast." This invention describes a process that utilizes an alkaline solution and an organic lysis solvent at high temperature and pressure. The method effectively lyses yeast cells and extracts squalene and/or sterol into an organic extraction solvent, resulting in high yields and purity of these valuable compounds.

Career Highlights

Haubrich is currently employed at Sanofi-Aventis Deutschland GmbH, where he continues to work on innovative projects that enhance the efficiency of biochemical processes. His expertise in fermentation technology and extraction methods has positioned him as a key player in his field.

Collaborations

Throughout his career, Andreas has collaborated with esteemed colleagues such as Gerhard Korb and Jean-Francois Trotzier. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the advancement of research in biochemistry.

Conclusion

Andreas Haubrich's contributions to the production of squalene and sterols highlight his innovative spirit and dedication to advancing biochemistry. His work not only benefits the pharmaceutical and cosmetic industries but also showcases the potential of yeast fermentation technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…